← Back to Clinical Trials
Recruiting Phase 4 NCT06003348
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
Trial Parameters
Condition Calcium Phosphate Kidney Stones
Sponsor University of Texas Southwestern Medical Center
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 25
Sex ALL
Min Age 21 Years
Max Age 99 Years
Start Date 2023-12-13
Completion 2028-05-31
Interventions
OHCit- standard dosePotassium CitratePlacebo
Brief Summary
This study tests whether hydroxycitrate, a molecule closely related to citrate, can reduce calcium phosphate stone recurrence.
Eligibility Criteria
Inclusion Criteria: \- Calcium Phosphate stone formers Exclusion Criteria: * History of recurrent urinary tract infections * Chronic diarrhea * Estimated Glomerular Filtration Rate (eGFR) \< 45 ml/min/1.73 m2 * History of primary hyperparathyroidism * Hypokalemia * Hyperkalemia * Pregnancy